Use of inhibitors of connexin43 for treatment of fibrotic conditions

Details for Australian Patent Application No. 2008343841 (hide)

Owner CoDa Therapeutics, Inc.

Inventors Becker, David L.; Duft, Bradford J.; Green, Colin R.

Agent Spruson & Ferguson

Pub. Number AU-A-2008343841

PCT Pub. Number WO2009/085270

Priority 61/008,795 21.12.07 US

Filing date 22 December 2008

Wipo publication date 9 July 2009

International Classifications

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61L 15/00 (2006.01) Chemical aspects of bandages, dressings, or absorbent pads or use of materials for their realisation

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/085270 Priority application(s): WO2009/085270

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008343842-Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions

2008343840-Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions